Global Parkinson’s Disease Treatment Market Size, Share, and COVID-19 Impact Analysis, By Drug Class (Carbidopa-Levodopa, Dopamine Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitor, Catechol-O-Methyltransferase (COMT) Inhibitors, and Others), By Route of Administration (Oral, Subcutaneous, Transdermal, and Others), By Distribution Channels (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Industry: Healthcare
RELEASE DATE Dec 2024
REPORT ID SI4618
PAGES 232
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Drug Class
      2. Market Attractiveness Analysis By Route of Administration
      3. Market Attractiveness Analysis By Distribution Channels
      4. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
    3. Government funding for research
    4. Restraints
      1.  Availability of alternative treatments
    5. Opportunities
      1.  Improved Diagnostic Tools
    6. Challenges
      1. High Cost of Treatment
  6. Global Parkinson’s Disease Treatment Market Analysis and Projection, By Drug Class
    1. Segment Overview
    2. Carbidopa-levodopa
    3. Dopamine Agonists
    4. Monoamine Oxidase Type B (MAO-B) Inhibitor
    5. Catechol-O-Methyltransferase (COMT) Inhibitor
    6. Others
  7. Global Parkinson’s Disease Treatment Market Analysis and Projection, By Route of Administration
    1. Segment Overview
    2. Oral
    3. Subcutaneous
    4. Transdermal
    5. Others
  8. Global Parkinson’s Disease Treatment Market Analysis and Projection, By Distribution Channels
    1. Segment Overview
    2. Hospital Pharmacy
    3. Retail Pharmacy
    4. Online Pharmacy
  9. Global Parkinson’s Disease Treatment Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  10. Global Parkinson’s Disease Treatment Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Parkinson’s Disease Treatment Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  11. Company Profiles
    1. Abbott Laboratories
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   General Electric Company 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Abbvie 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Merck & Co. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Pfizer 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Teva Pharmaceutical Industries Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Dr. Reddy’s Laboratories
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Sun Pharma
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Novartis AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Olatec Therapeutics 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Biotech Ltd
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Amneal Pharmaceuticals LLC
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  Zydus Cadila 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.  Hallamshire Physiotherapy Ltd
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    15. Others 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Parkinson’s Disease Treatment Market, By Drug Class, 2023-2033(USD Billion)
  2. Global Carbidopa-levodopa, Parkinson’s Disease Treatment Market, By Region, 2023-2033(USD Billion)
  3. Global Dopamine Agonists, Parkinson’s Disease Treatment Market, By Region, 2023-2033(USD Billion)
  4. Global Monoamine Oxidase Type B (MAO-B) Inhibitor, Parkinson’s Disease Treatment Market, By Region, 2023-2033(USD Billion)
  5. Global Catechol-O-Methyltransferase (COMT) Inhibitor, Parkinson’s Disease Treatment Market, By Region, 2023-2033(USD Billion)
  6. Global Others, Parkinson’s Disease Treatment Market, By Region, 2023-2033(USD Billion)
  7. Global Parkinson’s Disease Treatment Market, By Route of Administration, 2023-2033(USD Billion)
  8. Global Oral, Parkinson’s Disease Treatment Market, By Region, 2023-2033(USD Billion)
  9. Global Subcutaneous, Parkinson’s Disease Treatment Market, By Region, 2023-2033(USD Billion)
  10. Global Transdermal, Parkinson’s Disease Treatment Market, By Region, 2023-2033(USD Billion)
  11. Global Others, Parkinson’s Disease Treatment Market, By Region, 2023-2033(USD Billion)
  12. Global Parkinson’s Disease Treatment Market, By Distribution Channels, 2023-2033(USD Billion)
  13. Global Hospital Pharmacy, Parkinson’s Disease Treatment Market, By Region, 2023-2033(USD Billion)
  14. Global Retail Pharmacy, Parkinson’s Disease Treatment Market, By Region, 2023-2033(USD Billion)
  15. Global Online Pharmacy, Parkinson’s Disease Treatment Market, By Region, 2023-2033(USD Billion)
  16. North America Parkinson’s Disease Treatment Market, By Drug Class, 2023-2033(USD Billion)
  17. North America Parkinson’s Disease Treatment Market, By Route of Administration, 2023-2033(USD Billion)
  18. North America Parkinson’s Disease Treatment Market, By Distribution Channels, 2023-2033(USD Billion)
  19. U.S.  Parkinson’s Disease Treatment Market, By Drug Class, 2023-2033(USD Billion)
  20. U.S.  Parkinson’s Disease Treatment Market, By Route of Administration, 2023-2033(USD Billion)
  21. U.S.  Parkinson’s Disease Treatment Market, By Distribution Channels, 2023-2033(USD Billion)
  22. Canada Parkinson’s Disease Treatment Market, By Drug Class, 2023-2033(USD Billion)
  23. Canada Parkinson’s Disease Treatment Market, By Route of Administration, 2023-2033(USD Billion)
  24. Canada Parkinson’s Disease Treatment Market, By Distribution Channels, 2023-2033(USD Billion)
  25. Mexico Parkinson’s Disease Treatment Market, By Drug Class, 2023-2033(USD Billion)
  26. Mexico Parkinson’s Disease Treatment Market, By Route of Administration, 2023-2033(USD Billion)
  27. Mexico Parkinson’s Disease Treatment Market, By Distribution Channels, 2023-2033(USD Billion)
  28. Europe Parkinson’s Disease Treatment Market, By Drug Class, 2023-2033(USD Billion)
  29. Europe Parkinson’s Disease Treatment Market, By Route of Administration, 2023-2033(USD Billion)
  30. Europe Parkinson’s Disease Treatment Market, By Distribution Channels, 2023-2033(USD Billion)
  31. Germany Parkinson’s Disease Treatment Market, By Drug Class, 2023-2033(USD Billion)
  32. Germany Parkinson’s Disease Treatment Market, By Route of Administration, 2023-2033(USD Billion)
  33. Germany Parkinson’s Disease Treatment Market, By Distribution Channels, 2023-2033(USD Billion)
  34. France Parkinson’s Disease Treatment Market, By Drug Class, 2023-2033(USD Billion)
  35. France Parkinson’s Disease Treatment Market, By Route of Administration, 2023-2033(USD Billion)
  36. France Parkinson’s Disease Treatment Market, By Distribution Channels, 2023-2033(USD Billion)
  37. U.K.  Parkinson’s Disease Treatment Market, By Drug Class, 2023-2033(USD Billion)
  38. U.K.  Parkinson’s Disease Treatment Market, By Route of Administration, 2023-2033(USD Billion)
  39. U.K.  Parkinson’s Disease Treatment Market, By Distribution Channels, 2023-2033(USD Billion)
  40. Italy Parkinson’s Disease Treatment Market, By Drug Class, 2023-2033(USD Billion)
  41. Italy Parkinson’s Disease Treatment Market, By Route of Administration, 2023-2033(USD Billion)
  42. Italy Parkinson’s Disease Treatment Market, By Distribution Channels, 2023-2033(USD Billion)
  43. Spain Parkinson’s Disease Treatment Market, By Drug Class, 2023-2033(USD Billion)
  44. Spain Parkinson’s Disease Treatment Market, By Route of Administration, 2023-2033(USD Billion)
  45. Spain Parkinson’s Disease Treatment Market, By Distribution Channels, 2023-2033(USD Billion)
  46. Asia Pacific Parkinson’s Disease Treatment Market, By Drug Class, 2023-2033(USD Billion)
  47. Asia Pacific Parkinson’s Disease Treatment Market, By Route of Administration, 2023-2033(USD Billion)
  48. Asia Pacific Parkinson’s Disease Treatment Market, By Distribution Channels, 2023-2033(USD Billion)
  49. Japan Parkinson’s Disease Treatment Market, By Drug Class, 2023-2033(USD Billion)
  50. Japan Parkinson’s Disease Treatment Market, By Route of Administration, 2023-2033(USD Billion)
  51. Japan Parkinson’s Disease Treatment Market, By Distribution Channels, 2023-2033(USD Billion)
  52. China Parkinson’s Disease Treatment Market, By Drug Class, 2023-2033(USD Billion)
  53. China Parkinson’s Disease Treatment Market, By Route of Administration, 2023-2033(USD Billion)
  54. China Parkinson’s Disease Treatment Market, By Distribution Channels, 2023-2033(USD Billion)
  55. India Parkinson’s Disease Treatment Market, By Drug Class, 2023-2033(USD Billion)
  56. India Parkinson’s Disease Treatment Market, By Route of Administration, 2023-2033(USD Billion)
  57. India Parkinson’s Disease Treatment Market, By Distribution Channels, 2023-2033(USD Billion)
  58. South America Parkinson’s Disease Treatment Market, By Drug Class, 2023-2033(USD Billion)
  59. South America Parkinson’s Disease Treatment Market, By Route of Administration, 2023-2033(USD Billion)
  60. South America Parkinson’s Disease Treatment Market, By Distribution Channels, 2023-2033(USD Billion)
  61. Brazil Parkinson’s Disease Treatment Market, By Drug Class, 2023-2033(USD Billion)
  62. Brazil Parkinson’s Disease Treatment Market, By Route of Administration, 2023-2033(USD Billion)
  63. Brazil Parkinson’s Disease Treatment Market, By Distribution Channels, 2023-2033(USD Billion)
  64. The Middle East and Africa Parkinson’s Disease Treatment Market, By Drug Class, 2023-2033(USD   Billion)
  65. The Middle East and Africa Parkinson’s Disease Treatment Market, By Route of Administration, 2023-2033(USD   Billion)
  66. The Middle East and Africa Parkinson’s Disease Treatment Market, By Distribution Channels, 2023-2033(USD Billion)
  67. UAE Parkinson’s Disease Treatment Market, By Drug Class, 2023-2033(USD Billion)
  68. UAE Parkinson’s Disease Treatment Market, By Route of Administration, 2023-2033(USD Billion)
  69. UAE Parkinson’s Disease Treatment Market, By Distribution Channels, 2023-2033(USD Billion)
  70. South Africa Parkinson’s Disease Treatment Market, By Drug Class, 2023-2033(USD Billion)
  71. South Africa Parkinson’s Disease Treatment Market, By Route of Administration, 2023-2033(USD Billion)
  72. South Africa Parkinson’s Disease Treatment Market, By Distribution Channels, 2023-2033(USD Billion)

 

List of Figures 

  1. Global Parkinson’s Disease Treatment Market Segmentation
  2. Parkinson’s Disease Treatment Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Parkinson’s Disease Treatment Market
  9. Top Winning Strategies, 2023-2033
  10. Top Winning Strategies, By Development, 2023-2033(%)
  11. Top Winning Strategies, By Company, 2023-2033
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2023
  18. Market Share Analysis, 2023
  19. Restraint and Drivers:  Parkinson’s Disease Treatment Market
  20. Parkinson’s Disease Treatment Market Segmentation, By Drug Class
  21. Parkinson’s Disease Treatment Market For Carbidopa-levodopa, By Region, 2023-2033 ($ Billion)
  22.  Parkinson’s Disease Treatment Market For Dopamine Agonists, By Region, 2023-2033 ($ Billion)
  23. Parkinson’s Disease Treatment Market For Monoamine Oxidase Type B (MAO-B) Inhibitor, By Region, 2023-2033 ($ Billion)
  24. Parkinson’s Disease Treatment Market For Catechol-O-Methyltransferase (COMT) Inhibitor, By Region, 2023-2033 ($ Billion)
  25. Parkinson’s Disease Treatment Market For Others, By Region, 2023-2033 ($ Billion)
  26.  Parkinson’s Disease Treatment Market Segmentation, By Route of Administration
  27.  Parkinson’s Disease Treatment Market For Oral, By Region, 2023-2033 ($ Billion)
  28.  Parkinson’s Disease Treatment Market For Subcutaneous, By Region, 2023-2033 ($ Billion)
  29. Parkinson’s Disease Treatment Market For Transdermal, By Region, 2023-2033 ($ Billion)
  30. Parkinson’s Disease Treatment Market For Others, By Region, 2023-2033 ($ Billion)
  31. Parkinson’s Disease Treatment Market Segmentation, By Distribution Channels
  32. Parkinson’s Disease Treatment Market For Hospital Pharmacy, By Region, 2023-2033 ($ Billion)
  33. Parkinson’s Disease Treatment Market For Retail Pharmacy, By Region, 2023-2033 ($ Billion)
  34. Parkinson’s Disease Treatment Market For Online Pharmacy, By Region, 2023-2033 ($ Billion)
  35. Abbott Laboratories: Net Sales, 2023-2033 ($ Billion)
  36. Abbott Laboratories: Revenue Share, By Segment, 2023 (%)
  37. Abbott Laboratories: Revenue Share, By Region, 2023 (%)
  38. General Electric Company: Net Sales, 2023-2033 ($ Billion)
  39. General Electric Company: Revenue Share, By Segment, 2023 (%)
  40. General Electric Company: Revenue Share, By Region, 2023 (%)
  41. Abbvie: Net Sales, 2023-2033 ($ Billion)
  42. Abbvie: Revenue Share, By Segment, 2023 (%)
  43. Abbvie: Revenue Share, By Region, 2023 (%)
  44. Merck & Co.: Net Sales, 2023-2033 ($ Billion)
  45. Merck & Co.: Revenue Share, By Segment, 2023 (%)
  46. Merck & Co.: Revenue Share, By Region, 2023 (%)
  47. Pfizer: Net Sales, 2023-2033 ($ Billion)
  48. Pfizer: Revenue Share, By Segment, 2023 (%)
  49. Pfizer: Revenue Share, By Region, 2023 (%)
  50. Teva Pharmaceutical Industries Ltd.: Net Sales, 2023-2033 ($ Billion)
  51. Teva Pharmaceutical Industries Ltd.: Revenue Share, By Segment, 2023 (%)
  52. Teva Pharmaceutical Industries Ltd.: Revenue Share, By Region, 2023 (%)
  53. Dr. Reddy’s Laboratories: Net Sales, 2023-2033 ($ Billion)
  54. Dr. Reddy’s Laboratories: Revenue Share, By Segment, 2023 (%)
  55. Dr. Reddy’s Laboratories: Revenue Share, By Region, 2023 (%)
  56. Sun Pharma: Net Sales, 2023-2033 ($ Billion)
  57. Sun Pharma: Revenue Share, By Segment, 2023 (%)
  58. Sun Pharma: Revenue Share, By Region, 2023 (%)
  59. Novartis AG.: Net Sales, 2023-2033 ($ Billion)
  60. Novartis AG.: Revenue Share, By Segment, 2023 (%)
  61. Novartis AG.: Revenue Share, By Region, 2023 (%)
  62. Olatec Therapeutics: Net Sales, 2023-2033 ($ Billion)
  63. Olatec Therapeutics: Revenue Share, By Segment, 2023 (%)
  64. Olatec Therapeutics: Revenue Share, By Region, 2023 (%)
  65. Biotech Ltd: Net Sales, 2023-2033 ($ Billion)
  66. Biotech Ltd: Revenue Share, By Segment, 2023 (%)
  67. Biotech Ltd: Revenue Share, By Region, 2023 (%)
  68. Amneal Pharmaceuticals LLC: Net Sales, 2023-2033 ($ Billion)
  69. Amneal Pharmaceuticals LLC: Revenue Share, By Segment, 2023 (%)
  70. Amneal Pharmaceuticals LLC: Revenue Share, By Region, 2023 (%)
  71. Zydus Cadila: Net Sales, 2023-2033 ($ Billion)
  72. Zydus Cadila: Revenue Share, By Segment, 2023 (%)
  73. Zydus Cadila: Revenue Share, By Region, 2023 (%)
  74. Hallamshire Physiotherapy Ltd: Net Sales, 2023-2033 ($ Billion)
  75. Hallamshire Physiotherapy Ltd: Revenue Share, By Segment, 2023 (%)
  76. Hallamshire Physiotherapy Ltd: Revenue Share, By Region, 2023 (%)
  77. Others: Net Sales, 2023-2033 ($ Billion)
  78. Others: Revenue Share, By Segment, 2023 (%)
  79. Others: Revenue Share, By Region, 2023 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2023
Tables & Figures:115
Pages:232
Countries covered:17
Companies covered::19
Forecast CAGR:6.41%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies